Are Berkshire Hathaways best days behind it? Warren Buffett seems to think so. In an essay to mark the firms 50th anniversary, the Oracle of Omaha wrote in 2015 that Berkshire Hathaways future long-term gains will not come close to those achieved in the past 50 years. (The words in italics are reproduced exactly as they appeared.) The numbers have become too big, Buffett goes on to say about....More>>>
I don't know about you, but I'm fascinated by "world champions" – folks who have literally reached the top of their game. I've been fortunate to meet a lot folks like this (in a variety of fields… namely sports, business, and music). A lot of my own success comes from learning directly from them, and mimicking things they do. I'm SO curious....More>>>
Making his first extended comments since Fox News dropped his top-rated show last week, Bill O’Reilly said he was taken aback by how his 21-year run at the network came to an end.
“I am sad that I’m not on television anymore,” O’Reilly said in a podcast posted Monday on his official website. “I was very surprised how it all turned out. I can’t....More>>>
During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.
After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 82 big blue chips.
Chances are that you have at least one of these....More>>>
"I personally sold all my gold and gold stocks yesterday," I told a crowd of 500 gold bugs at the Sprott Natural Resource Symposium in Vancouver at the end of July. The crowd was shocked… But my timing was nearly perfect. Gold is down 12% since the beginning of August. And gold stocks – as measured by the VanEck Vectors Junior Gold Miners Fund (GDXJ) –....More>>>
Portola Pharmaceuticals (NASDAQ:PTLA) was one of the year’s most hotly anticipated biotech IPOs when it was brought public by Morgan Stanley and Credit Suisse in May 2013 at $14.50/share. Shares quickly rose to the mid-$20s, but then did little afterwards for the next 18 months.
Since that time though, Portola has taken shareholders on a ludicrous ride and now the story has....More>>>